Recommending a Big Pharma Play with Growing Momentum

Nicholas Vardy

Nicholas Vardy has a unique background that has proven his knack for making money in different markets around the world.

With U.S. stocks pulling back sharply on Friday, you hit three of your stops on your current Momentum Trader Alert positions, booking some solid double-digit-percentage gains.

Stryker Corp (SYK) stopped out at $141.90 for a 10.33% gains. The Cooper Companies (COO) stopped out at $236.15 for a 20.01% gain.

In addition, Broadcom Ltd (AVGO) stopped out at $248.50 for a 10.48% gain.

This week’s Momentum Trader Alert takes you back into the realm of pharmaceuticals and biotech.

Incorporated in 2012 and based in North Chicago, Illinois, AbbVie Inc. (ABBV) is one of the nation’s largest pharmaceutical companies. The company’s three most important drugs on the market today are Humira (rheumatoid arthritis), Imbruvica (cancer) and Viekira Pak (Hepatitis C). AbbVie started its corporate life as a spin-off of Abbott Laboratories (ABT).

AbbVie Inc. (ABBV) versus the S&P 500 year to date.

Momentum Trader Alert Analysis


Buy AbbVie Inc. (ABBV) at market today and place your stop at $65.00.

I am holding off on recommending options for now as last week’s sharp move upwards has made the options very expensive.

Portfolio Update

With United Technologies (UTX) pulling back last week, I am recommending that you buy the UTX August $120 calls (UTX170818C00120000), which last traded at $3.25 and expire on Aug. 18, to take advantage of the stock’s coming rebound.


Nicholas Vardy

Nicholas A. Vardy

Exclusive  Booking Double-Digit Percentage Option Gains and Cleaning up Your Portfolio

Like This Article?
Now Get Our FREE Special Report:
Alternative Investing: Investing in Timber

Stock Investor editor Paul Dykewicz reveals why investing in timber may be one of the best long-term portfolio strategies you'll find today.

Get Access to the Report, 100% FREE

previous article

It is easy for investors to feel pessimistic these days, but America and her stock market are riding high on the world stage.


Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details


Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details


Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details


Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details


Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details


Used by financial advisors and individual investors all over the world, is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.